Filtered By:
Condition: ALS
Therapy: Stem Cell Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 62 results found since Jan 2013.
The microRNAs (miRs) overexpressing mesenchymal stem cells (MSCs) therapy in neurological disorders; hope or hype
AbstractAltered expression of multiple miRNAs was found to be extensively involved in the pathogenesis of different neurological disorders including Alzheimer's disease, Parkinson's disease, stroke, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. One of the biggest concerns within gene-based therapy is the delivery of the therapeutic microRNAs to the intended place, which is obligated to surpass the biological barriers without undergoing degradation in the bloodstream or renal excretion. Hence, the delivery of modified and unmodified miRNA molecules using excellent vehicles is require...
Source: Biotechnology Progress - September 6, 2023 Category: Biotechnology Authors: Sulieman Ibraheem Shelash Al ‐Hawary,
Anas Yahya Ali,
Yasser Fakri Mustafa,
Ria Margiana,
Shamsutdinova Maksuda Ilyasovna,
Montather F. Ramadan,
Sami G. Almalki,
Marim Alwave,
Safa Alkhayyat,
Ali Alsalamy Tags: REVIEW Source Type: research
The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System
CONCLUSION: It was shown that MSCs, independent from origin or administration pathway, can reduce inflammation and help in the recovery and preservation of injured neural tissue. Thus, the use of MSCs represents a potential therapeutic option in the treatment of neurological disorders mediated by inflammatory processes.PMID:36398461 | DOI:10.1159/000528036
Source: Neuro-Degenerative Diseases - November 18, 2022 Category: Neurology Authors: Rodrigo de Andrade Rufino La ís da Silva Pereira-Rufino Thays Cristina Silva Vissoto Irina Kerkis Adriana da Costa Neves Marcelo Cavenaghi Pereira da Silva Source Type: research
